Emerging therapies for hepatitis C virus-Reference-Cited by-同舟云学术

Emerging therapies for hepatitis C virus

Published:2010-07-15 Issue:4 Volume:15 Page:535-544
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Birerdinc Aybike,Younossi Zobair M

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728214.2010.502527

Reference65 articles.

1. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology. Williams & Wilkins, Philadelphia, Lippincott; 2001. p. 991-1042

2. Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

3. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

4. The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

5. Update on viral hepatitis: 2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase;Journal of Biomolecular Structure and Dynamics;2019-03-27

2. 3D-QSAR and molecular docking studies on designing inhibitors of the hepatitis C virus NS5B polymerase;Journal of Molecular Structure;2016-08

3. Application and Progress of Organic Synthesis in the Discovery of Innovative Drugs;Chinese Journal of Organic Chemistry;2015

4. Boceprevir in genotype 1 chronic hepatitis C: First experiences in Serbia;Srpski arhiv za celokupno lekarstvo;2015

5. PEGylation and its impact on the design of new protein-based medicines;Future Medicinal Chemistry;2014-10